Decrypt · Joint health

Is glucosamine really effective for dogs?

An older golden retriever resting its head on a wooden beam
Short answerProbably not. Glucosamine is the most-studied ingredient in canine joint care and one of the least convincing: the largest review of the field found it produced no measurable effect in the overwhelming majority of trials. It stays on shelves because it is cheap and familiar, not because the evidence improved.

What glucosamine actually is

Glucosamine is an amino sugar. Your dog's body already makes it, and uses it as a building block for the glycosaminoglycans that give cartilage its ability to hold water and absorb load. That biology is real, and it is the entire basis of the marketing: cartilage is made partly of glucosamine, so feeding glucosamine should help rebuild cartilage.

It is a tidy story. The problem is that it treats the body like a warehouse, where anything you deliver ends up where you want it. Bodies do not work that way.

Where the glucosamine in the jar comes from

It does not come from cartilage. The glucosamine in almost every supplement on the market is produced industrially by acid hydrolysis of chitin, the hard structural material in shrimp and crab shells. The shells are broken down with strong acid, and the resulting glucosamine is purified and salted, usually into glucosamine hydrochloride or glucosamine sulfate. A smaller share is now made by fermenting corn, which is how shellfish-free versions exist.

This matters for two reasons. It is why glucosamine is a shellfish allergen concern, and it is why it costs almost nothing: the raw material is seafood-industry waste, and the process is straightforward chemistry at industrial scale.

The trial that made its reputation

The high-water mark came in 2007. McCarthy and colleagues gave 35 dogs with confirmed hip or elbow osteoarthritis either a glucosamine-chondroitin combination or carprofen, an anti-inflammatory drug, and followed them for 70 days. The supplement group improved significantly on pain, weight-bearing and overall severity.

That study is still quoted in marketing today, so it is worth reading it properly. It had no placebo group: glucosamine was compared against a drug, not against nothing. Outcomes were scored subjectively by the attending veterinarians rather than measured objectively. And it had 35 dogs. In a condition where owners and vets both want to see improvement, and where dogs get good days and bad days on their own, a small trial with no placebo arm and subjective scoring is a weak instrument.

Then the evidence went the other way

In 2017, a review in Open Veterinary Journal gathered the canine literature on glucosamine and chondroitin and described it plainly as limited and conflicting, while noting that veterinarians were recommending these products anyway.

The decisive result came in 2022. A team at the University of Montreal screened nearly 1,600 publications and analysed 72 clinical trials covering 38 compounds in dogs and cats, scoring each trial for methodological quality as well as outcome. For glucosamine-chondroitin, 88.9% of trials showed no effect at all, and none showed an effect against a control group. On averaged efficacy scores, the negative control groups actually did better. The authors concluded these products should no longer be recommended for pain management in canine and feline osteoarthritis.

That is unusually blunt language for a scientific paper, and it did not come from a single unlucky study. It came from the whole body of work.

Why it does not work

The mechanism was measured 20 years ago. In beagles given oral doses, mean bioavailability was around 12% for glucosamine hydrochloride and about 5% for chondroitin sulfate. Roughly nine tenths of what your dog swallows never reaches the bloodstream, let alone the joint. Whatever the label promises about rebuilding cartilage, the material largely does not arrive.

So why is it still in everything?

Because it is cheap, and because the name is doing work that the molecule is not. Owners recognise glucosamine, so it sells. It costs a manufacturer very little per dose, so a bag can be filled with it and still look generous on the label. And a long ingredient list headed by a familiar word is easier to market than an unfamiliar ingredient with better trials behind it.

None of this makes glucosamine dangerous. Its safety record is benign, and if your dog is on it, there is no urgency to stop today. But if you are choosing what to buy next, check what the first three ingredients are and what the trials say about them. In the same 2022 analysis, omega-3 fatty acids showed the strongest evidence of any compound studied. That is a better place to spend the money.

This article is general information, not veterinary advice. Talk to your own veterinarian before changing anything about your dog's regimen.

Sources
McCarthy G. et al., Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis, The Veterinary Journal 2007;174(1):54–61.
pubmed.ncbi.nlm.nih.gov/16647870

Bhathal A., Spryszak M., Louizos C., Frankel G., Glucosamine and chondroitin use in canines for osteoarthritis: a review, Open Veterinary Journal 2017;7(1):36–49.
pubmed.ncbi.nlm.nih.gov/28331832

Barbeau-Grégoire M. et al., A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis, Int. J. Mol. Sci. 2022;23(18):10384.
doi.org/10.3390/ijms231810384

Adebowale A. et al., The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs, Biopharmaceutics & Drug Disposition 2002;23(6):217–225.
pubmed.ncbi.nlm.nih.gov/12214321